CHRONIC MYELOGENOUS LEUKEMIA (CML)
Clinical trials for CHRONIC MYELOGENOUS LEUKEMIA (CML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA (CML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOGENOUS LEUKEMIA (CML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One donor, two transplants: experimental procedure aims to cure blood cancer and fix kidneys
Disease control CompletedThis pilot study tested a combined transplant from a partially matched family donor. It aimed to treat patients who had both a serious blood disorder (like leukemia) and advanced kidney disease at the same time. The goal was to cure the blood disorder and restore kidney function …
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA (CML)
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
A multicenter, randomized, phase III registration trial of transplantation of NiCord®, ex vivo expanded, UCB-derived, stem and progenitor cells, vs. unmanipulated UCB for patients with hematological malignancies
CompletedThis study is an open-label, controlled, multicenter, international, Phase III, randomized study of transplantation of NiCord® versus transplantation of one or two unmanipulated, unrelated cord blood units in patients with acute lymphoblastic leukemia or acute myeloid leukemia, m…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA (CML)
Phase: PHASE3 • Sponsor: Gamida Cell ltd
Last updated Mar 02, 2026 15:25 UTC